Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Motif Bio
Motif Bio
The FDA is forcing a small antibiotic player back to the clinic for a new trial — 10 years after first rejection
Endpoints
Thu, 06/6/19 - 09:52 am
Motif Bio
FDA
antibiotics
Iclaprim